Phase 4 Psoriasis trials recruiting now
All Psoriasis trials, every phase
30
Phase 4 recruiting
Other phases for Psoriasis
Phase 4 Psoriasis trials
- A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers
- A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treating Chinese Children With Severe Plaque Psoriasis
- A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
- A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
- A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
- A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
- Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis
- Correction of Psoriatic T Cell Signatures by Deucravacitinib
- Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
- Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
- Duobrii in Combination With Biologics
- Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
- Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
- ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
- Immune Spatial Features of Guselkumab Cutaneous Response
- Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial
- Multi-Center PAMPA Study
- Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
- Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.
- Preventing Structural Damage in Early Psoriatic Arthritis
- Proactive TDM Versus Standard Use of Biologics in Psoriasis
- Psoriatic Immune Response to Tildrakizumab
- REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
- Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
- Taltz in Combination With Enstilar for Psoriasis
- The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
- Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant
Common questions
What does Phase 4 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.